Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorIstituto Oncologico Veneto IRCCS
About this trial
ONCO-MinD is a multicentre, cross-sectional, non-interventional mixed-method study aimed at investigating healthcare providers' attitudes towards oncology patients with mental disorders in Italian cancer centres. The study will assess levels of mental health-related stigma among healthcare professionals and explore factors associated with these attitudes, including professional background, clinical setting, experience, and previous exposure to mental health conditions. Quantitative survey data collected using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC) will be integrated with qualitative findings from semi-structured interviews to provide a comprehensive understanding of how stigma may influence clinical relationships, decision-making processes, and equity of cancer care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Healthcare professionals working in participating oncology centres.
Physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants.
Direct involvement in the clinical care of oncology patients.
Employed at one of the participating study sites at the time of enrolment.
Disqualifiers
Refusal to participate or failure to provide informed consent.
Students in training.
Healthcare personnel working in services with very limited patient contact and without direct responsibility for oncology patient care.
Trial population
The study population consists of healthcare professionals working in oncology settings at participating Italian cancer centres. Eligible participants include physicians, nurses, psychologists, radiation therapy technologists, and healthcare assistants directly involved in the care of oncology patients. Participants will be recruited through exhaustive sampling across participating institutions and invited to complete an anonymous survey. A purposive sample of survey participants may subsequently be invited to participate in semi-structured interviews as part of the qualitative phase of the study.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
OMS-HC Questionnaire and Semi-Structured Interviews
Other interventionParticipants complete an anonymous questionnaire and, where selected, participate in a semi-structured interview for research data collection purposes. No clinical or behavioural intervention is administered.
Treatment groups
1,000 Participants
are divided into 1 treatment groupGroup A: Oncology Healthcare Professionals1 intervention
Trial outcomes
Primary outcomes
1
Mental health-related stigma among oncology healthcare professionals
Level of stigma towards people with mental disorders measured using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC). The total score ranges from 15 to 75, with higher scores indicating greater stigma and lower scores indicating more positive attitudes towards people with mental disorders.
Time frame
At survey completion (up to 3 months)Secondary outcomes
1
Factors Associated With OMS-HC Scores
Association between OMS-HC scores and healthcare professionals' socio-demographic and professional characteristics, including age, sex, professional role, education, clinical area, years of experience, previous mental health experience, and perceived mental health training.
Time frame
Up to 3 months2
Healthcare professionals' experiences and perceptions regarding oncology patients with mental disorders
Qualitative themes identified through semi-structured interviews, including perceived barriers to care, diagnostic overshadowing, impact of psychiatric comorbidity on clinical decision-making, relational challenges, and facilitators to improve cancer care.
Time frame
Up to 9 months3
Integrated mixed-method understanding of stigma towards oncology patients with mental disorders
Integration of quantitative survey findings and qualitative interview data through joint displays and meta-inferences to provide a comprehensive understanding of mental health-related stigma among oncology healthcare professionals, including its determinants, manifestations, and perceived impact on cancer care delivery and clinical decision-making.
Time frame
Up to 13 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Istituto Oncologico Veneto IRCCS
Lead sponsor
Centro di Riferimento Oncologico - Aviano
Collaborator
Istituti Tumori Giovanni Paolo II
Collaborator
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Collaborator
IRCCS Centro di Riferimento Oncologico della Basilicata
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: